Limitation of myocardial infarct size after primary angioplasty: Is a higher patency the only mechanism?
- 30 June 1999
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 137 (6) , 1169-1172
- https://doi.org/10.1016/s0002-8703(99)70378-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Randomized Comparison of Primary Coronary Angioplasty With Thrombolytic Therapy in Low Risk Patients With Acute Myocardial InfarctionJournal of the American College of Cardiology, 1997
- Primary Angioplasty Versus Thrombolysis in the Treatment of Acute Myocardial InfarctionThe American Journal of Cardiology, 1997
- Is coronary thrombolysis associated with side effects that significantly compromise clinical benefits?The American Journal of Cardiology, 1996
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.Circulation, 1993
- Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studiesJournal of the American College of Cardiology, 1993
- A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapyJournal of the American College of Cardiology, 1987